ArticleJournal of fluorescence2026
A Label-Free Graphene Quantum Dot-Based Fluorescent Aptasensor for Rapid and Sensitive Detection of Leptospira interrogans.
Article in Journal of fluorescence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Leptospirosis is a neglected tropical disease that is widespread in tropical and subtropical regions. The lack of rapid and sensitive diagnostic tools continues to limit the early identification of the disease. In this study, a graphene quantum dots-based aptasensor was developed for the detection of Leptospira interrogans. Graphene quantum dots were synthesized and used as fluorescence transducers, which are covalently conjugated with cell surface-specific DNA aptamer targeting the pathogen. The synthesized quantum dots exhibited quasi-spherical morphology with particle size ranging from ~ 2.5 nm. Upon target recognition, the GQD-aptamer conjugate exhibited concentrationdependent fluorescence quenching, showing a linear response over the range of 10³-10⁸ CFU/mL (R² = 0.958) and a limit of detection of 10³ CFU mL⁻¹. The assay was completed within 15 min. The sensing platform was further evaluated under biologically relevant conditions, including protein-containing buffer, heat-treated cells, diluted serum, and artificial urine samples. In addition to spectroscopic analysis, dark-field microscopy revealed pronounced aggregation and clustering of Leptospira cells following treatment with the GQD-aptamer conjugate. The combined spectroscopic and microscopic findings support the proposed sensing mechanism and highlight the potential of the developed GQD-aptamer platform as a rapid fluorescence-based aptasensor for Leptospira, with future applicability towards point-of-care diagnostic development.
Indexed as
Identifiers
42722934What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.